Novartis Investigative Site

Fayetteville, Arkansas 72703

0 studies enrolling now · 5 studies all time

What they study most

Cardiovascular Disease, Chronic Obstructive Pulmonary Disease, Metastatic Renal Cell Carcinoma, Multiple Myeloma, Neoplasms, Breast, Type 2 Diabetes Mellitus

Studies at this site

• Panobinostat/Bortezomib/Dexamethasone in Relapsed or Relapsed-and-refractory Multiple Myeloma — Completed
• Efficacy and Safety Study of QVA149 in COPD Patients — Completed
• EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer — APPROVED_FOR_MARKETING
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early
• RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or Sunitinib — Completed